AMP German Cannabis Group adds Little Green Pharma medical cannabis extracts from Australia to its sales offering



AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028), providing German patients with a wide range of pharmaceutical grade medical cannabis products, is pleased to announce it will be adding Little Green Pharma Ltd. (ASX: LGP) cannabis oil medicines to its catalogue for sale in Germany beginning in November 2020 subject to obtaining a BtM-registration (narcotic drug licence) of these products on behalf of AMP.

AMP is looking forward to offering premium EU-GMP full plant extract cannabis oil medicines branded under the LGP Classic brand, produced by the same consistent strains.  AMP wants to introduce the LGP brand to the German market by selling “LGP Classic 20:5 Oils” (THC dominant) and additional products in the near term once AMP has established the brand in the German market. Whereas LGP`s full plant extracts originate from the same cannabis plants, many other cannabis extracts are sourced from varying cannabis plants.

Little Green Pharma is licenced to cultivate and produce medical cannabis in Australia and has obtained the required licences and permits to export to Germany. Little Green Pharma has its own Therapeutic Goods Administration (“TGA”) GMP licensed manufacturing facility in addition to a six-year, exclusive manufacturing agreement with a third-party TGA-GMP licensed contract manufacturer based in Western Australia. The TGA-GMP certification, granted by Australia’s Department of Health, is recognized by EU regulatory authorities as meeting EU-GMP standards enabling LGP products to be sold in Germany.

Dr. Stefan Feuerstein, Director and President of AMP, said: “We had a lot of requests for medical cannabis oils during our recent sales trip through Germany, where we met with medium-sized distributors and large pharmacists that are specializing in medical cannabis.  To meet this demand, we are introducing the premium LGP Classic brand as our first extract brand for the German market. We wanted our first extract in our product line to be a premium, full plant extract that our sales team can introduce along with our other medical cannabis flower products. We will be adding additional cannabis oils in the coming months to satisfy our customers’ strong demand for this product line.”

Ms. Fleta Solomon, Managing Director of Little Green Pharmacommented, “Our focus is on producing the highest quality cannabis medicines for Australia and other countries where medicinal cannabis has been legalized. We are proud to be the first Australian company to supply Germany, the leading medicinal cannabis market in Europe, and that AMP will be introducing the LGP Classic brand.  We expect strong sales from AMP as they immediately launch and invest in introducing our LGP Classic 20:5 oil to the German market and additional LGP Classic products in the near term.”


Please enter your comment!
Please enter your name here